Sunshine Biopharma, Inc.
SBFM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7 | $0 | $5 | $8 |
| - Cash | $9 | $10 | $8 | $10 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | -$2 | -$9 | -$2 | -$1 |
| Revenue | $9 | $9 | $9 | $10 |
| % Growth | 0.1% | 5.7% | -7.2% | – |
| Gross Profit | $3 | $3 | $3 | $3 |
| % Margin | 32.6% | 36.4% | 30.7% | 32.2% |
| EBITDA | -$1 | -$2 | -$1 | -$2 |
| % Margin | -9.8% | -20.3% | -13% | -23.1% |
| Net Income | -$1 | -$2 | -$1 | -$2 |
| % Margin | -9.4% | -18.8% | -13.3% | -22.5% |
| EPS Diluted | -0.19 | -7.8 | -0.44 | -0.84 |
| % Growth | 97.6% | -1,672.7% | 47.6% | – |
| Operating Cash Flow | -$1 | -$1 | -$2 | -$3 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$2 | -$2 | -$4 |